Articles By Anuja Singh
Did Ophthalmic Therapy Approvals in 2025 Redefine Vision Care—and Set the Stage for Accelerated…
Global – December 2025 — The ophthalmology therapeutic area entered a renewed phase of innovation in 2025, driven…
ByDid Metabolic Therapy Approvals in 2025 Reset the Standard of Care—and Ignite a New…
Global – December 2025 — The metabolic therapeutic area emerged as one of the most transformative forces in…
Did Renal Therapy Approvals in 2025 Redefine Kidney Disease Management—and Set the Stage for…
Global – December 2025 — The renal therapeutic area emerged as a renewed focus of innovation in 2025,…
Did Cardiovascular Approvals in 2025 Signal a New Era in Heart Disease Management—and Set…
Global – December 2025 — The cardiovascular (CV) therapeutic area re-emerged as a strategic growth engine in 2025,…
Did Infectious Disease Approvals in 2025 Redefine Global Preparedness—and Set the Course for Innovation…
Global – December 2025 — The infectious diseases (ID) landscape underwent a structural recalibration in 2025, shaped by…
Did Neuroscience Approvals in 2025 Mark a Turning Point—and Set the Stage for a…
Global – December 2025 — The neuroscience sector experienced a long-anticipated resurgence in 2025, driven by regulatory approvals…
Did Ophthalmic Therapy Approvals in 2025 Redefine Vision Care—and Set the Stage for Accelerated…
Global – December 2025 — The ophthalmology therapeutic area entered a renewed phase of innovation in 2025, driven…
Did Metabolic Therapy Approvals in 2025 Reset the Standard of Care—and Ignite a New…
Global – December 2025 — The metabolic therapeutic area emerged as one of the most transformative forces in…
Did Renal Therapy Approvals in 2025 Redefine Kidney Disease Management—and Set the Stage for…
Global – December 2025 — The renal therapeutic area emerged as a renewed focus of innovation in 2025,…
Did Cardiovascular Approvals in 2025 Signal a New Era in Heart Disease Management—and Set…
Global – December 2025 — The cardiovascular (CV) therapeutic area re-emerged as a strategic growth engine in 2025,…
Did Infectious Disease Approvals in 2025 Redefine Global Preparedness—and Set the Course for Innovation…
Global – December 2025 — The infectious diseases (ID) landscape underwent a structural recalibration in 2025, shaped by…
Did Neuroscience Approvals in 2025 Mark a Turning Point—and Set the Stage for a…
Global – December 2025 — The neuroscience sector experienced a long-anticipated resurgence in 2025, driven by regulatory approvals…